The 15th issue of the Scientific Update is co-edited by Manuel Peitsch, Prof., Chief Scientific Officer. It describes our commitment to advancing our ambition of achieving a smoke-free future for adults who would otherwise continue to smoke, the scientists working to make that goal a reality, and a look at the smoke-free products that we're building that future on.
This issue on our transformation towards a smoke-free future examines our rigorous scientific assessment program and the work conducted by some of our scientists and R & D experts. This issue details the range of smoke-free products in our portfolio as we continue to leverage science and technology to develop, assess, and commercialize less harmful alternatives to cigarettes.
PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.
Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.